Browse > Article
http://dx.doi.org/10.5483/BMBRep.2018.51.2.168

The role of Purkinje cell-derived VEGF in cerebellar astrogliosis in Niemann-Pick type C mice  

Park, Min Hee (Stem Cell Neuroplasticity Research Group, Kyungpook National University)
Lee, Ju Youn (Stem Cell Neuroplasticity Research Group, Kyungpook National University)
Jeong, Min Seock (Stem Cell Neuroplasticity Research Group, Kyungpook National University)
Jang, Hyung Sup (Stem Cell Neuroplasticity Research Group, Kyungpook National University)
Endo, Shogo (Aging Neuroscience Research Team, Tokyo Metropolitan Institute of Gerontology)
Bae, Jae-sung (Stem Cell Neuroplasticity Research Group, Kyungpook National University)
Jin, Hee Kyung (Stem Cell Neuroplasticity Research Group, Kyungpook National University)
Publication Information
BMB Reports / v.51, no.2, 2018 , pp. 79-84 More about this Journal
Abstract
Niemann-Pick type C disease (NP-C) is a fatal neurodegenerative disorder caused by a deficiency of NPC1 gene function, which leads to severe neuroinflammation such as astrogliosis. While reports demonstrating neuroinflammation are prevalent in NP-C, information about the onset and progression of cerebellar astrogliosis in this disorder is lacking. Using gene targeting, we generated vascular endothelial growth factor (VEGF) conditional null mutant mice. Deletion of VEGF in cerebellar Purkinje neurons (PNs) led to a significant increase of astrogliosis in the brain of NP-C mice in addition to the loss of PNs, suggesting PN-derived VEGF as an important factor in NP-C pathology. Moreover, replenishment of VEGF in neurons improved brain pathology in NP-C mice. Overall, our data provide a new pathological perspective on cerebellar astrogliosis in NP-C and suggest the importance of VEGF as a therapeutic target for this disease.
Keywords
Cerebellar astrogliosis; Niemann-Pick type C disease; Purkinje neuron; Vascular endothelial growth factor;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Wang Y, Kilic E, Kilic U et al (2005) VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain 128, 52-63
2 Tabata T, Sawada S, Araki K, Bono Y, Furuya S and Kano M (2000) A reliable method for culture of dissociated mouse cerebellar cells enriched for Purkinje neurons. J Neurosci Methods 104, 45-53   DOI
3 Gerber HP, Hillan KJ, Ryan AM et al (1999) VEGF is required for growth and survival in neonatal mice. Development 126, 1149-1159
4 Karten B, Vance DE, Campenot RB and Vance JE (2002) Cholesterol accumulates in cell bodies, but is decreased in distal axons, of Niemann-Pick C1-deficient neurons. J Neurochem 83, 1154-1163   DOI
5 Vanier MT and Millat G (2003) Niemann-Pick disease type C. Clin Genet 64, 269-281   DOI
6 Lee H, Lee JK, Park MH et al (2014) Pathological roles of the VEGF/SphK pathway in Niemann-Pick type C neurons. Nat Commun 5, 5514   DOI
7 Pentchev PG, Comly ME, Kruth HS et al (1985) A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc Natl Acad Sci U S A 82, 8247-8251   DOI
8 Sarna JR, Larouche M, Marzban H, Sillitoe RV, Rancourt DE and Hawkes R (2003) Patterned Purkinje cell degeneration in mouse models of Niemann-Pick type C disease. J Comp Neurol 456, 279-291   DOI
9 Zhang XM, Ng AH, Tanner JA et al (2004) Highly restricted expression of Cre recombinase in cerebellar Purkinje cells. Genesis 40, 45-51   DOI
10 Bae JS, Furuya S, Ahn SJ, Yi SJ, Hirabayashi Y and Jin HK (2005) Neuroglial activation in Niemann-Pick Type C mice is suppressed by intracerebral transplantation of bone marrow-derived mesenchymal stem cells. Neurosci Lett 381, 234-236   DOI
11 Elrick MJ, Pacheco CD, Yu T et al (2010) Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration. Hum Mol Genet 19, 837-847   DOI
12 Lange C, Storkebaum E, de Almodovar CR, Dewerchin M and Carmeliet P (2016) Vascular endothelial growth factor: a neurovascular target in neurological diseases. Nat Rev Neurol 12, 439-454
13 Licht T, Goshen I, Avital A et al (2011) Reversible modulations of neuronal plasticity by VEGF. Proc Natl Acad Sci U S A 108, 5081-5086   DOI
14 Giaume C, Kirchhoff F, Matute C, Reichenbach A and Verkhratsky A (2007) Glia: the fulcrum of brain diseases. Cell Death Differ 14, 1324-1335   DOI
15 Nimmerjahn A (2009) Astrocytes going live: advances and challenges. J Physiol 587, 1639-1647   DOI
16 Baudry M, Yao Y, Simmons D, Liu J and Bi X (2003) Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia. Exp Neurol 184, 887-903   DOI
17 German DC, Liang CL, Song T, Yazdani U, Xie C and Dietschy JM (2002) Neurodegeneration in the Niemann- Pick C mouse: glial involvement. Neuroscience 109, 437-450   DOI
18 Yu T, Shakkottai VG, Chung C and Lieberman AP (2011) Temporal and cell-specific deletion establishes that neuronal Npc1 deficiency is sufficient to mediate neurodegeneration. Hum Mol Genet 20, 4440-4451   DOI
19 Patel SC, Suresh S, Kumar U et al (1999) Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease. Proc Natl Acad Sci U S A 96, 1657-1662   DOI
20 Lopez ME, Klein AD, Dimbil UJ and Scott MP (2011) Anatomically defined neuron-based rescue of neurodegenerative Niemann-Pick type C disorder. J Neurosci 31, 4367-4378   DOI
21 Vanier MT (2010) Niemann-Pick disease type C. Orphanet J Rare Dis 5, 16   DOI
22 Davidson CD, Ali NF, Micsenyi MC et al (2009) Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS One 4, e6951   DOI
23 Lopez AM, Terpack SJ, Posey KS, Liu B, Ramirez CM and Turley SD (2014) Systemic administration of 2-hydroxypropyl-${\beta}$-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function. Clin Exp Pharmacol Physiol 41, 780-787   DOI
24 Camargo F, Erickson RP, Garver WS et al (2001) Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease. Life Sci 70, 131-142   DOI
25 Hovakimyan M, Maass F and Petersen J (2013) Combined therapy with cyclodextrin/allopregnanolone and miglustat improves motor but not cognitive functions in Niemann-Pick Type C1 mice. Neuroscience 252, 201-211   DOI
26 Williams IM, Wallom KL, Smith DA, Al Eisa N, Smith C, Platt FM (2014) Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice. Neurobiol Dis 67, 9-17   DOI